Title: Kan He - Innovator in Pharmaceutical Science
Introduction
Kan He is a notable inventor based in the United States, recognized for his contributions to pharmaceutical science. His work primarily focuses on developing compounds that have significant therapeutic potential.
Latest Patents
Kan He has developed a patent titled "Quinazolinediones And Their Use." This invention discloses compounds of formula (I), or pharmaceutically acceptable salts or prodrugs thereof, which inhibit the poly(ADP-ribose) polymerases (PARP). These compounds are useful for treating diseases, disorders, and conditions related to PARP. The invention also includes pharmaceutical compositions comprising a compound of formula (I) and methods of using such compounds to inhibit PARP enzymes.
Career Highlights
Kan He is currently employed at Eternity Bioscience Inc., where he continues to innovate in the field of drug development. His work is pivotal in advancing treatments for various medical conditions.
Collaborations
Kan He collaborates with Dong Liu, enhancing the research and development efforts at Eternity Bioscience Inc. Their combined expertise contributes to the advancement of pharmaceutical innovations.
Conclusion
Kan He is a dedicated inventor whose work in pharmaceutical science holds promise for future medical advancements. His innovative approach to drug development is paving the way for new treatments.